https://pathomiq.com/myriad-genetics-partners-with-pathomiq-to-add-artificial-intelligence-technology-platform-to-its-oncology-portfolio/2025-09-22T19:52:37+00:00https://pathomiq.com/pathomiq-and-neuberg-diagnostics-partner-to-deploy-novel-ai-based-prognostic-and-predictive-biomarker-tests-in-clinical-practice/2025-09-22T19:55:36+00:00https://pathomiq.com/pathomiq-announces-data-presentation-on-an-ai-powered-tool-that-predicts-response-of-triple-negative-breast-cancer-to-neoadjuvant-chemotherapy-at-the-san-antonio-breast-cancer-symposium-sabcs-2022/2025-09-22T19:59:06+00:00